Skip to content

Ashland Hyderabad laboratory receives ISO certification

Press Release

<< Back
03/06/2023

Ashland Hyderabad laboratory receives ISO certification

WILMINGTON, Del., March 6, 2023 – Ashland’s life sciences laboratory in Hyderabad, India has attained ISO 17025:2017 certification, an international standard for laboratory management that sets the requirements for a laboratory's competence, impartiality, and consistent operation.

“We are thrilled to achieve ISO 17025 certification,” said Nelson David Corda, general manager, life sciences, Asia Pacific. “It strengthens our ability to thoroughly support our regional customers while providing critical global support as an additional qualified lab for quality retests and stability work.”

Meeting the ISO standard at the Ashland Hyderabad lab provides the following benefits:

  • Enhanced quality of services; certification demands strict adherence to accurate and immaculate procedures
  • Customer trust through high-quality analytical services and competent results.
  • Better cost control with improved processes
  • Superior risk management as ISO 17025 requires a laboratory to assess and manage potential risks to its operations
  • Improved efficiency through adherence to ISO 17025 requirements

“Achieving ISO certification in our Hyderabad lab signals another important step in the achievement of our long-term strategy.” said Ashok Kalyana, senior vice president and general manager, Life Sciences, Ashland, “We are building on our global capability to be responsive to our customers’ needs as they solve for performance attributes that will allow patients to take medicine in more convenient and tolerable ways.”

Ashland’s pharmaceutical business is well known for acetylenics, cellulosics, and film coatings, and these polymers have a rich and diverse history supporting active pharmaceutical ingredient delivery. Deploying resources to build on existing high impact and high value technologies, Ashland is widening its portfolio of cellulose-based polymers (HPMC, HPC, CMC, HEC, EC), growing its excipient portfolio for injectables and biologics, including the possibility for customization, and focusing on film coatings that meet customer needs.

 

About Ashland

Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environment, social and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care and pharmaceutical. Approximately 3,900 passionate, tenacious solvers – from renowned scientists and research chemists to talented engineers and plant operators – thrive on developing practical, innovative and elegant solutions to complex problems for customers in more than 100 countries.

 

Visit ashland.com and ashland.com/ESG to learn more.

Trademark, Ashland or its subsidiaries, registered in various countries.

 

  FOR FURTHER INFORMATION:

Media Relations, India:

Media Relations, Global:

Rajani Bhatt

+91 75068 10026

rajani.bhatt@ashland.com

 

 

Nancy H. Pitts

+1 (412)628-8791

nancy.pitts@ashland.com